Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Bénédicte Debiol"'
Autor:
Zhiyar Abdulrahman, Hamza Bennani Naciri, Asma Allal, Federico Sallusto, Bénédicte Debiol, Laure Esposito, Céline Guilbeau-Frugier, Nassim Kamar, Lionel Rostaing
Publikováno v:
Journal of Nephropathology, Vol 6, Iss 4, Pp 290-303 (2017)
Background: ABO-incompatible (ABOi) is as efficient as ABO-compatible (ABOc) kidneytransplantation in the setting of live-donation. Objectives: To evaluate the long-term outcomes (i.e. >6 months) of 44 consecutive ABOi living-donor kidney-transplants
Externí odkaz:
https://doaj.org/article/aafcfe95c0bc4033aee3a2020a1b43eb
Autor:
Lionel Rostaing, Asma Allal, Arnaud del Bello, Federico Sallusto, Laure Esposito, Nicolas Doumerc, Bénédicte Debiol, Audrey Delas, Xavier Game, Nassim Kamar
Publikováno v:
Journal of Nephropathology, Vol 5, Iss 3, Pp 90-97 (2016)
Background: ABO-incompatible (ABOi) kidney-transplantation has very good long-term results, i.e. similar to those observed for living-kidney ABO-compatible transplantation. This is because patients are desensitized at pretransplant using apheresis an
Externí odkaz:
https://doaj.org/article/61832baae4ea46b09ea61545ba3efeaa
Autor:
Hamza Naciri Bennani, Zhyiar Abdulrahman, Asma Allal, Federico Sallusto, Antoine Delarche, Xavier Game, Laure Esposito, Nicolas Doumerc, Bénédicte Debiol, Nassim Kamar, Lionel Rostaing
Publikováno v:
Journal of Nephropathology, Vol 5, Iss 1, Pp 19-27 (2016)
Background: Living-kidney transplantation is increasing because of the scarcity of kidneys from deceased donors and the increasing numbers of patients on waiting lists for a kidney transplant. Living-kidney transplantation is now associated with incr
Externí odkaz:
https://doaj.org/article/644fb8bdcd4147f68fe1380f8c903cff
Autor:
Federico Sallusto, Laure Esposito, Asma Allal, Bénédicte Debiol, Nassim Kamar, Hamza Bennani Naciri, Lionel Rostaing, Zhiyar Abdulrahman, Céline Guilbeau-Frugier
Publikováno v:
Journal of Nephropathology. 6:290-303
Background: ABO-incompatible (ABOi) is as efficient as ABO-compatible (ABOc) kidneytransplantation in the setting of live-donation. significantly more BKV viruria in ABOi (25%) vs. 6.8% in ABOc (P = 0.03). De novo donor-specific alloantibody were det
Autor:
Jean-Baptiste Thibert, Laurent Bardiaux, Olga Samsonova, Frédéric Garban, Bénédicte Debiol, Yohan Desbrosses, Thi Ngoc Phuong Huynh, Ibrahim Yakoub-Agha, Tamim Alsuliman, Bénédicte Bruno, Christine Giraud
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2019, 106, pp.S52-S58. ⟨10.1016/j.bulcan.2018.08.016⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.S52-S58. ⟨10.1016/j.bulcan.2018.08.016⟩
Bulletin du Cancer, 2019, 106, pp.S52-S58. ⟨10.1016/j.bulcan.2018.08.016⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.S52-S58. ⟨10.1016/j.bulcan.2018.08.016⟩
The recommendations of the French Health and Drug Safety Authorities (HAS/ANSM-Haute Autorite de sante/Agence nationale de securite du medicament) are known, but there are always new developments underway. With regards to CMV suppression, there is th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b408dc565722165cb0c74beabe4d4aa
https://hal.science/hal-03486642/document
https://hal.science/hal-03486642/document
Autor:
Nicolas Congy-Jolivet, Bénédicte Debiol, Gaëlle Dörr, Katy Trébern-Launay, Lionel Rostaing, L. Esposito, David Milongo, A. Del Bello, Inès Ferrandiz, Nassim Kamar
Publikováno v:
American Journal of Transplantation
American Journal of Transplantation, Wiley, 2016, 16 (9), pp.2661-2669. ⟨10.1111/ajt.13795⟩
American Journal of Transplantation, 2016, 16 (9), pp.2661-2669. ⟨10.1111/ajt.13795⟩
American Journal of Transplantation, Wiley, 2016, 16 (9), pp.2661-2669. ⟨10.1111/ajt.13795⟩
American Journal of Transplantation, 2016, 16 (9), pp.2661-2669. ⟨10.1111/ajt.13795⟩
International audience; Little is known about the impact of posttransplant blood transfusion on the sensitization of anti-HLA antibodies and the formation of donor-specific antibodies (DSAs). The aims of our study were to determine the 1-year incide
Autor:
Federico Sallusto, Béatrice Karam, Nicolas Congy-Jolivet, Nicolas Doumerc, Valérie Hage, Xavier Gamé, Asma Allal, Laure Esposito, Céline Guilbeau-Frugier, Bénédicte Debiol, Lionel Rostaing, Nassim Kamar
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:507-516
Few studies have assessed the outcomes of ABOi/HLAi living-kidney transplantation. We report a single-center experience of 12 ABOi/HLAi living-kidney recipients. Twenty-seven donor-specific alloantibodies (DSAs) (1-6 per patient) were found with fluo
Autor:
Christine, Giraud, Jean-Baptiste, Thibert, Yohan, Desbrosses, Bénédicte, Debiol, Tamim, Alsuliman, Laurent, Bardiaux, Frédéric, Garban, Thi Ngoc Phuong, Huynh, Olga, Samsonova, Ibrahim, Yakoub-Agha, Bénédicte, Bruno
Publikováno v:
Bulletin du cancer. 106(1S)
The recommendations of the French Health and Drug Safety Authorities (HAS/ANSM-Haute Autorité de santé/Agence nationale de sécurité du médicament) are known, but there are always new developments underway. With regards to CMV suppression, there
Autor:
Nicolas Doumerc, Lionel Rostaing, Asma Allal, Nassim Kamar, Laure Esposito, Xavier Gamé, Bénédicte Debiol, Arnaud Del Bello, Federico Sallusto, Audrey Delas
Publikováno v:
Journal of Nephropathology
Background: ABO-incompatible (ABOi) kidney-transplantation has very good long-term results, i.e. similar to those observed for living-kidney ABO-compatible transplantation. This is because patients are desensitized at pretransplant using apheresis an
Autor:
Lionel Rostaing, Nicolas Doumerc, Xavier Gamé, Laure Esposito, Asma Allal, Bénédicte Debiol, Hamza Naciri Bennani, Nassim Kamar, Federico Sallusto, Zhyiar Abdulrahman, Antoine Delarche
Publikováno v:
Journal of Nephropathology
Background: Living-kidney transplantation is increasing because of the scarcity of kidneys from deceased donors and the increasing numbers of patients on waiting lists for a kidney transplant. Living-kidney transplantation is now associated with incr